✦ LIBER ✦

Effects of hepatic impairment on the pharmacokinetics of nilotinib: An open-label, single-dose, parallel-group study

✍ Scribed by Ophelia Q.P. Yin; Neil Gallagher; Chiaki Tanaka; Deirdre Fisher; Venkat Sethuraman; Wei Zhou; Tsu-Han Lin; Douglas Heuman; Horst Schran

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of Hepatic Impairment on the Pha

✍ Peveling-Oberhag, Jan; Zeuzem, Stefan; Yong, Wei Peng; Kunz, Tiffany; Paquet, Th 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 994 KB

An Open-Label, Single-Dose, Parallel-Gro

✍ Baird-Bellaire, Susan; Behrle, Jessica A.; Parker, Vernon D.; Patat, Alain; Paul 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 267 KB

Influence of Hepatic Impairment on the P

✍ Sreeneeranj Kasichayanula; Xiaoni Liu; Weijiang Zhang; Marc Pfister; Frank P. La 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 813 KB

Pharmacokinetics of Pilsicainide Hydroch

✍ Qiu, Qi; Liu, Wenfang; Li, Jing; Wei, Yongxiang; Yang, Kexu; Suo, Wei; Wu, Wei; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 174 KB

Effects of hepatic impairment on the ste

✍ Monika Schöller-Gyüre; Thomas N. Kakuda; Goedele De Smedt; Brian Woodfall; Cindy 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 851 KB

Effect of Hepatic Impairment on the Phar

✍ Steven L. Bramer, William P. Forbes 📂 Article 📅 1999 🏛 Springer International Publishing AG 🌐 English ⚖ 133 KB